Antibodies

Items 431-440 of 643

per page
Set Descending Direction
  1. anti-LPS (Legionella pneumophila), mAb (rec.) (PHK121-H2)
    AG-27B-6325
    AG-27B-6325-C05050 µg
    CHF 330.00
  2. anti-MART1 (human), Rabbit Monoclonal (RM333)
    REV-31-1220-00
    REV-31-1220-00-R100100 µl
    CHF 459.00
    Immunohistochemical staining of formalin fixed and paraffin embedded human melanoma tissue section using anti-MART1 rabbit monoclonal antibody (Clone RM333) at a 1:1000 dilution.
  3. anti-MDA5 (human), mAb (Hely-1)
    AG-20B-0013
    AG-20B-0013-C100100 µg
    CHF 460.00
  4. anti-MDA5 (mouse), pAb (AL180)
    AG-25B-0001V
    AG-25B-0001V-C100100 µg
    CHF 440.00
    Western blot analysis anti-MDA5 (mouse), pAb (AL180) (Prod. No. AG-25B-0001) detecting the cleavage of endogenous mouse MDA5 as an indicator of apoptosis. Method: Cleavage of endogenous Helicard in murine A20 B lymphomas undergoing Fas-mediated apo
  5. anti-MerTK (human), Rabbit Monoclonal (RM506)
    REV-31-1398-00
    REV-31-1398-00-R100100 µl
    CHF 459.00
    anti-MerTK (human), Rabbit Monoclonal (RM506)
  6. anti-MerTK (mouse), Rabbit Monoclonal (RM469)
    REV-31-1361-00
    REV-31-1361-00-R100100 µl
    CHF 459.00
    anti-MerTK (mouse), Rabbit Monoclonal (RM469)
  7. anti-Methylglyoxal [MG], mAb (3C)
    JAI-MMG-030N.
    JAI-MMG-030N30 µg
    CHF 830.00
    Immunohistochemical staining of MG adducts in atherosclerotic aorta using anti-MG, mAb (3C).
  8. anti-MFAP4 (human), pAb
    AG-25A-0061
    AG-25A-0061-C100100 µg
    CHF 190.00
    Western blot analysis using anti-MFAP4 (human), pAb (Prod. No. AG-25A-0061) at 1:2'000 dilution.
1: Human MFAP4 (FLAG®-tagged).
2: Mouse RBP4 (FLAG®-tagged) (negative control).
  9. anti-MHC Class II (human), mAb (TDR31.1)
    ANC-131-020.
    ANC-131-020100 µg
    CHF 260.00
  10. anti-MHC Class II (human), mAb (TDR31.1) (APC)
    ANC-131-060.
    ANC-131-060120 tests
    CHF 551.00

Items 431-440 of 643

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.